Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures - Global Forecasts to 2018

NEW YORK, April 7, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures – Global Forecasts to 2018
http://www.reportlinker.com/p02063459/Pediatric-Interventional-Cardiology-Market-By-Congenital-Heart-Defect-Closure-Device-[ASD-Ventricular-Septal-Defect-Patent-Ductus-Arteriosus-Left-Atrial-Appendage-Aortic-Valve-Pulmonary-Valve]--Procedures-–-Global-Forecasts-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

The global pediatric interventional cardiology market is a very dynamic market, as this market is witnessing a number of technological advancements, owing to which various new devices are being launched in the market. Traditionally, pediatric interventional cardiology was used for diagnostic purposes; however, currently, it is increasingly being used for treatment purposes as well. The transcatheter heart valve market is the fastest growing segment in the pediatric interventional cardiology market. In 2010, the first pediatric specific transcatheter pulmonary heart valve was launched in the U.S. market. Companies in this market are engaged in the development of new and improved transcatheter heart valves, which is a major reason for its high growth. In addition, this market is witnessing a number of venture capitalist investments, which is aiding in the development and launch of new products in this market.

In the coming years, the APAC and RoW regions are expected to grow at high CAGRs. These regions offer an array of opportunities for growth and are expected to be the new revenue pockets in the pediatric interventional cardiology market. Both these regions offer a high growth potential as compared to mature markets such as Europe. Growth in these markets is spurred by the growing incidence of congenital heart disease (CHD). According to the American College of Cardiology Foundation, in 2010, the prevalence of CHD in Asia was 8.9 to 9.7 per 1,000 live births, whereas in Africa this figure was 1.1 to 3.5 per 1,000 live births. The APAC region is witnessing a number of collaborations between local players and foreign companies for the development of new products. Also, the APAC region is hosting a number of conferences and workshops for discussing new and advanced techniques that are present in the market. These conferences and workshops will help in stimulating innovation in the field of pediatric interventional cardiology, thus aiding the market to grow further.

The global pediatric interventional cardiology market is highly competitive and all the existing players in this market are engaged in developing new and advanced products, to maintain their market share. However, varied stringency of regulatory procedures across the globe and the presence of complex regulatory procedures are the factors that are likely to hinder the growth of this market. At present, difficulties encountered in clinical trials of pediatric medical devices such as patient recruitment and high cost are the major challenges faced by market players.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauze the pulse of the market, which in turn would help the firms in garnering a greater market share. Firms purchasing this report could use any one or a combination of the below mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping a greater market share.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on product portfolios and services offered by the top players in the pediatric interventional cardiology market. The report also provides the number of cath labs and the number of pediatric cardiology procedures performed across geographies

• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the pediatric interventional cardiology market


• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the promising applications of pediatric interventional cardiology devices across geographies

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pediatric interventional cardiology market

• Competitive Assessment: In depth assessment of market shares, strategies, products and services, distribution networks, manufacturing capabilities of leading players, and porters five forces analysis in the pediatric interventional cardiology market

1 INTRODUCTION 19

1.1 OBJECTIVES OF THE STUDY 19
1.2 REPORT DESCRIPTION 19
1.3 MARKETS COVERED 21
1.4 STAKEHOLDERS 22
1.5 SCOPE 22
1.6 RESEARCH METHODOLOGY 22
1.6.1 MARKET SIZE ESTIMATION 25
1.6.2 MARKET CRACKDOWN & DATA TRIANGULATION 26
1.6.3 MARKET SHARE CALCULATION 28
1.6.4 KEY DATA POINTS FROM PRIMARY SOURCES 28
1.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 29
1.6.6 ASSUMPTIONS 30

2 EXECUTIVE SUMMARY 31

3 PREMIUM INSIGHTS 35

3.1 INVESTMENT TRENDS 36
3.2 TECHNOLOGY TRENDS 37
3.3 REGULATORY ENVIRONMENT 38
3.3.1 REGULATORY APPROVAL PROCEDURES FOR PEDIATRIC CARDIOLOGY DEVICES 38
3.3.1.1 510(K) Application 38
3.3.1.2 Premarket Approval (PMA) Application 38
3.3.1.3 Humanitarian Device Exemption (HDE) Application 40
3.3.2 INTELLECTUAL PROPERTY PROTECTION AND PATENT LITIGATION 40
3.4 REIMBURSEMENT SCENARIO: TRANSCATHETER HEART VALVES 42
3.5 PORTER'S FIVE FORCES ANALYSIS: PEDIATRIC INTERVENTIONAL CARDIOLOGY IMAGING MARKET 44
3.5.1 THREAT OF NEW ENTRANTS 44
3.5.2 BARGAINING POWER OF SUPPLIERS 45
3.5.3 BARGAINING POWER OF BUYERS 45
3.5.4 COMPETITOR RIVALRY 46
3.5.5 THREAT OF SUBSTITUTES 46
3.6 UNMET NEED 47
3.6.1 PEDIATRIC-SPECIFIC CARDIAC DEVICES 47
3.7 WINNING IMPERATIVES 47
3.7.1 INVESTMENTS IN R&D ACTIVITIES 47
3.7.2 ACQUISITIONS 48

4 MARKET OVERVIEW 49

4.1 MARKET DYNAMICS 50
4.1.1 MARKET DRIVERS 51
4.1.1.1 Pediatric Interventional Cardiology Devices 51
4.1.1.1.1 Government support, an impetus for the pediatric interventional cardiology market 51
4.1.1.1.2 Awareness programs and conferences to fuel the market 53
4.1.1.1.3 Rising incidences of congenital heart defects(CHD)to propel the pediatric interventional cardiology market 54
4.1.1.1.4 Technological advancements to open new opportunities for device manufacturers 54
4.1.1.1.5 Advantages of minimally invasive procedures over conventional surgeries to propel the market growth 55
4.1.1.2 Pediatric Cardiology Imaging 56
4.1.1.2.1 FDA's efforts to bolster the pediatric cardiology imaging market 56
4.1.2 MARKET RESTRAINTS 57
4.1.2.1 Pediatric Interventional Cardiology Devices 57
4.1.2.1.1 Complex regulatory procedures 57
4.1.2.1.2 Varied stringency of regulatory procedures delays product launches 57
4.1.2.2 Pediatric Cardiology Imaging 58
4.1.2.2.1 Implementation of excise tax by the U.S. government 58
4.1.3 MARKET OPPORTUNITIES 58
4.1.3.1 Pediatric Interventional Cardiology Devices 58
4.1.3.1.1 Advances in biodegradable devices for pediatric cardiology 58
4.1.3.1.2 Asia-Pacific region presents significant growth opportunities 59
4.1.3.1.3 Robust growth in the transcatheter heart valves market 59
4.1.3.2 Pediatric Cardiology Imaging 60
4.1.3.2.1 Mobile cath labs, an upcoming opportunity area 60
4.1.4 CHALLENGES 61
4.1.4.1 Pediatric Interventional Cardiology Devices 61
4.1.4.1.1 Difficulties in pediatric clinical trials 61
4.1.4.2 Pediatric Cardiology Imaging 62
4.1.4.2.1 High cost of pediatric interventional cardiology imaging devices 62
4.1.4.2.2 Survival of small players and new entrants 62
4.2 MARKET SHARE ANALYSIS 63
4.2.1 STRUCTURAL HEART DEFECT CLOSURE DEVICES 63
4.2.2 TRANSCATHETER HEART VALVES 65

5 PEDIATRIC INTERVENTIONAL CARDIOLOGY PROCEDURES 67

5.1 INTRODUCTION 68
5.2 NORTH AMERICA 71
5.3 EUROPE 72
5.4 APAC 73
5.5 ROW 75

6 PEDIATRIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET 77

6.1 INTRODUCTION 78
6.2 HEART DEFECT CLOSURE DEVICES 84
6.2.1 ASD, VSD, & PFO CLOSURE DEVICES 88
6.2.1.1 Atrial septal defect (ASD) Closure devices 91
6.2.1.2 Ventricular septal defect (VSD) closure devices 93
6.2.1.3 Patent foramen ovale (PFO) closure devices 94
6.2.2 PATENT DUCTUS ARTERIOSUS (PDA) CLOSURE DEVICES 98
6.2.3 LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICES 103
6.3 TRANSCATHETER HEART VALVES 108
6.3.1 TRANSCATHETER PULMONARY VALVES 112
6.3.2 TRANSCATHETER AORTIC VALVES (TAV) 117
6.4 OTHERS 123
6.4.1 ANGIOPLASTY BALLOONS 126
6.4.2 ANGIOPLASTY STENTS 127
6.4.3 CATHETERS 129
6.4.4 GUIDEWIRES 129

7 GEOGRAPHIC ANALYSIS 130

7.1 INTRODUCTION 131
7.2 EUROPE 134
7.2.1 GERMANY 137
7.2.2 FRANCE 139
7.2.3 U.K. 140
7.2.4 ITALY 142
7.2.5 SPAIN 143
7.2.6 ROE 145
7.3 NORTH AMERICA 147
7.3.1 U.S. 149
7.3.2 CANADA 151
7.4 ASIA-PACIFIC (APAC) 153
7.5 REST OF THE WORLD (ROW) 156

8 COMPETITIVE LANDSCAPE 158

8.1 PEDIATRIC INTERVENTIONAL CARDIOLOGY IMAGING MARKET 158
8.1.1 INTRODUCTION 158
8.1.2 NEW PRODUCT LAUNCHES 159
8.1.3 ACQUISITIONS 160
8.1.4 AGREEMENTS 161
8.1.5 EXPANSIONS 162
8.1.6 APPROVALS 163
8.2 PEDIATRIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET 164
8.2.1 INTRODUCTION 164
8.2.2 ACQUISITIONS 165
8.2.3 AGREEMENTS 167
8.2.4 NEW PRODUCT LAUNCHES 168
8.2.5 OTHER DEVELOPMENTS 169
8.2.6 APPROVALS 170

9 COMPANY PROFILES 176 (Overview, Financials, Products & Services, Strategy, & Developments)*

9.1 IMAGING PRODUCTS COMPANIES 176
9.1.1 GE HEALTHCARE
(SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 176
9.1.2 SIEMENS HEALTHCARE
(SUBSIDIARY OF SIEMENS AG) 182
9.1.3 TOSHIBA CORPORATION 188
9.2 PEDIATRIC INTERVENTIONAL CARDIOLOGY DEVICE COMPANIES 193
9.2.1 EDWARDS LIFESCIENCES 193
9.2.2 GORE MEDICAL
(SUBSIDIARY OF W.L. GORE & ASSOCIATES) 200
9.2.3 MEDTRONIC, INC. 203
9.2.4 ST. JUDE MEDICAL 210
9.2.5 ABBOTT VASCULAR
(A SUBSIDIARY OF ABBOTT LABORATORIES) 217
9.2.6 BOSTON SCIENTIFIC CORPORATION 223
9.2.7 CORDIS CORPORATION
(SUBSIDIARY OF JOHNSON & JOHNSON) 229
9.2.8 NUMED, INC. 235
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

LIST OF TABLES

TABLE 1 PEDIATRIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY GEOGRAPHY, 2011-2018 ($MILLION) 33
TABLE 2 NUMBER OF PEDIATRIC INTERVENTIONAL CARDIOLOGY PROCEDURES, BY GEOGRAPHY, 2012–2018 69
TABLE 3 GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY DEVICE TYPE, 2011–2018 ($MILLION) 80
TABLE 4 PEDIATRIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY GEOGRAPHY, 2011–2018 ($MILLION) 81
TABLE 5 NORTH AMERICA: PEDIATRIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2011–2018 ($MILLION) 82
TABLE 6 EUROPE: PEDIATRIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2011–2018 ($MILLION) 83
TABLE 7 HEART DEFECT CLOSURE DEVICES MARKET, BY DEVICE TYPE,
2011–2018 ($MILLION) 84
TABLE 8 HEART DEFECT CLOSURE DEVICES MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 85
TABLE 9 NORTH AMERICA: HEART DEFECT CLOSURE DEVICES MARKET,
BY COUNTRY, 2011–2018 ($MILLION) 86
TABLE 10 EUROPE: HEART DEFECT CLOSURE DEVICES MARKET,
BY COUNTRY, 2011–2018 ($MILLION) 87
TABLE 11 PEDIATRIC ASD, VSD, & PFO CLOSURE DEVICES MARKET,
BY GEOGRAPHY, 2011–2018 ($MILLION) 89
TABLE 12 NORTH AMERICA: PEDIATRIC ASD, VSD, & PFO CLOSURE DEVICES MARKET, BY COUNTRY, 2011–2018 ($MILLION) 90
TABLE 13 EUROPE: PEDIATRIC ASD, VSD, & PFO CLOSURE DEVICES MARKET,
BY COUNTRY, 2011–2018 ($MILLION) 91
TABLE 14 MAJOR ATRIAL SEPTAL DEVICES 92
TABLE 15 MAJOR VENTRICULAR SEPTAL DEFECT CLOSURE DEVICES 94
TABLE 16 MAJOR PATENT FORAMEN OVALE CLOSURE DEVICES 96
TABLE 17 MAJOR PATENT DUCTUS ARTERIOSUS CLOSURE DEVICES 99
TABLE 18 PEDIATRIC PDA CLOSURE DEVICES MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 100
TABLE 19 NORTH AMERICA: PEDIATRIC PDA CLOSURE DEVICES MARKET,
BY COUNTRY, 2011–2018 ($MILLION) 101
TABLE 20 EUROPE: PEDIATRIC PDA CLOSURE DEVICES MARKET,
BY COUNTRY, 2011–2018 ($MILLION) 102
TABLE 21 MAJOR LEFT ATRIAL APPENDAGE CLOSURE DEVICES 103
TABLE 22 PEDIATRIC LAA CLOSURE DEVICES MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 105
TABLE 23 NORTH AMERICA: PEDIATRIC LAA CLOSURE DEVICES MARKET,
BY COUNTRY, 2011–2018 ($MILLION) 106
TABLE 24 EUROPE: PEDIATRIC LAA CLOSURE DEVICES MARKET, BY COUNTRY, 2011–2018 ($MILLION) 107
TABLE 25 TRANSCATHETER HEART VALVES MARKET, BY DEVICE TYPE,
2011–2018 ($MILLION) 108
TABLE 26 TRANSCATHETER HEART VALVES MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 109
TABLE 27 NORTH AMERICA: TRANSCATHETER HEART VALVES MARKET,
BY COUNTRY, 2011–2018 ($MILLION) 110
TABLE 28 EUROPE: TRANSCATHETER HEART VALVES MARKET, BY COUNTRY, 2011–2018 ($MILLION) 111
TABLE 29 MAJOR TRANSCATHETER PULMONARY VALVE 113
TABLE 30 PEDIATRIC TRANSCATHETER PULMONARY VALVE DEVICE MARKET,
BY GEOGRAPHY, 2011–2018 ($MILLION) 114
TABLE 31 NORTH AMERICA: TRANSCATHETER PULMONARY VALVES MARKET,
BY COUNTRY, 2011–2018 ($MILLION) 115
TABLE 32 EUROPE: TRANSCATHETER PULMONARY VALVES MARKET, BY COUNTRY, 2011–2018 ($MILLION) 116
TABLE 33 MAJOR TRANSCATHETER AORTIC VALVES 117
TABLE 34 PEDIATRIC TRANSCATHETER AORTIC VALVE DEVICE MARKET,
BY GEOGRAPHY, 2011–2018 ($MILLION) 120
TABLE 35 NORTH AMERICA: TRANSCATHETER AORTIC VALVES MARKET,
BY COUNTRY, 2011–2018 ($MILLION) 121
TABLE 36 EUROPE: TRANSCATHETER AORTIC VALVES MARKET, BY COUNTRY, 2011–2018 ($MILLION) 122
TABLE 37 OTHER DEVICES MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 124
TABLE 38 NORTH AMERICA: OTHER DEVICES MARKET, BY COUNTRY,
2011–2018 ($MILLION) 125
TABLE 39 EUROPE: OTHER DEVICES MARKET, BY COUNTRY,
2011–2018 ($MILLION) 126
TABLE 40 PEDIATRIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY GEOGRAPHY, 2011–2018 ($MILLION) 133
TABLE 41 EUROPE: PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET,
BY DEVICE TYPE, 2011–2018 ($MILLION) 136
TABLE 42 GERMANY: PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET,
BY DEVICE TYPE, 2011–2018 ($MILLION) 138
TABLE 43 FRANCE: PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET,
BY DEVICE TYPE, 2011–2018 ($MILLION) 140
TABLE 44 U.K.: PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET,
BY DEVICE TYPE, 2011–2018 ($MILLION) 141
TABLE 45 ITALY: PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET, BY DEVICE TYPE, 2011–2018 ($MILLION) 143
TABLE 46 SPAIN: PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET, BY DEVICE TYPE, 2011–2018 ($MILLION) 144
TABLE 47 REST OF EUROPE: PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET, BY DEVICE TYPE, 2011–2018 ($MILLION) 146
TABLE 48 NORTH AMERICA: PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET, BY DEVICE TYPE, 2011–2018 ($MILLION) 148
TABLE 49 U.S.: PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET, BY DEVICE TYPE, 2011–2018 ($MILLION) 150
TABLE 50 CANADA: PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET,
BY DEVICE TYPE, 2011–2018 ($MILLION) 152
TABLE 51 ASIA-PACIFIC (APAC): PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET, BY DEVICE TYPE, 2011–2018 ($MILLION) 155
TABLE 52 ROW: PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET, BY DEVICE TYPE, 2011–2018 ($MILLION) 157
TABLE 53 NEW PRODUCT LAUNCH, 2011-2013 159
TABLE 54 ACQUISITIONS, 2011-2013 161
TABLE 55 AGREEMENTS, 2011-2013 162
TABLE 56 EXPANSIONS, 2011-2013 163
TABLE 57 APPROVALS, 2011-2013 163
TABLE 58 ACQUSITIONS, 2011-2013 166
TABLE 59 AGREEMENTS, 2011-2013 167
TABLE 60 NEW PRODUCT LAUNCH, 2011-2013 168
TABLE 61 OTHER DEVELOPMENTS, 2011-2013 169
TABLE 62 APPROVALS, 2011-2014 171
TABLE 63 GENERAL ELECTRIC: TOTAL REVENUE AND R&D EXPENDITURE,
2011–2013 ($MILLION) 177
TABLE 64 GENERAL ELECTRIC: TOTAL REVENUE, BY SEGMENT,
2011–2013 ($MILLION) 177
TABLE 65 GENERAL ELECTRIC: TOTAL REVENUE, BY GEOGRAPHY,
2011–2013 ($BILLION) 178
TABLE 66 SIEMENS HEALTHCARE: TOTAL REVENUE AND R&D EXPENDITURE, 2011–2013 ($MILLION) 182
TABLE 67 SIEMENS HEALTHCARE: TOTAL REVENUE, BY SEGMENT,
2011–2013 ($MILLION) 183
TABLE 68 SIEMENS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY,
2011–2013 ($MILLION) 184
TABLE 69 TOSHIBA CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2011–2013 ($BILLION) 188
TABLE 70 TOSHIBA CORPORATION: TOTAL REVENUE, BY SEGMENT,
2011–2013 ($BILLION) 189
TABLE 71 TOSHIBA CORPORATION: TOTAL REVENUE, BY GEOGRAPHY,
2011–2013 ($BILLION) 190
TABLE 72 EDWARDS LIFESCIENCES: TOTAL REVENUE AND R&D EXPENDITURE, 2010–2012 ($MILLION) 194
TABLE 73 EDWARDS LIFESCIENCES: TOTAL REVENUE, BY SEGMENT,
2010–2012 ($MILLION) 194
TABLE 74 EDWARDS LIFESCIENCES: TOTAL REVENUE, BY GEOGRAPHY,
2010–2012 ($MILLION) 195
TABLE 75 MEDTRONIC, INC.: TOTAL REVENUE AND R&D EXPENDITURE,
2011–2013 ($MILLION) 203
TABLE 76 MEDTRONIC, INC.: TOTAL REVENUE, BY SEGMENT,
2011–2013 ($MILLION) 204
TABLE 77 MEDTRONIC, INC.: TOTAL REVENUE, BY GEOGRAPHY,
2011–2013 ($MILLION) 204
TABLE 78 ST. JUDE MEDICAL: TOTAL REVENUE AND R&D EXPENDITURE,
2011–2013 ($MILLION) 211
TABLE 79 ST. JUDE MEDICAL: TOTAL REVENUE, BY SEGMENT,
2011–2013 ($MILLION) 211
TABLE 80 ST. JUDE MEDICAL: TOTAL REVENUE, BY GEOGRAPHY,
2011–2013 ($MILLION) 212
TABLE 81 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENDITURE, 2011–2013 ($MILLION) 218
TABLE 82 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENT,
2011–2013 ($MILLION) 218
TABLE 83 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY,
2011–2013 ($MILLION) 219
TABLE 84 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2011-2013 ($MILLION) 223
TABLE 85 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENT, 2011–2013 ($MILLION) 224
TABLE 86 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2011–2013 ($MILLION) 225
TABLE 87 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENDITURE, 2011–2013 ($MILLION) 230
TABLE 88 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENT,
2011–2013 ($MILLION) 230
TABLE 89 JOHNSON & JOHNSON: MEDICAL DEVICES AND DIAGNOSTIC SEGMENT REVENUE, BY SEGMENT, 2011–2013 ($MILLION) 231
TABLE 90 JOHNSON & JOHNSON: MEDICAL DEVICES AND DIAGNOSTIC SEGMENT REVENUE, BY GEOGRAPHY, 2011–2013 ($MILLION) 232

LIST OF FIGURES

FIGURE 1 FORECAST MODEL 23
FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY 25
FIGURE 3 DATA TRIANGULATION 27
FIGURE 4 NUMBER OF PEDIATRIC INTERVENTIONAL CARDIOLOGY PROCEDURES, 2012–2018 32
FIGURE 5 MAJOR PATENT INFRINGEMENT CASES 41
FIGURE 6 PORTER'S FIVE FORCES ANALYSIS 44
FIGURE 7 MARKET DYNAMICS 51
FIGURE 8 STRUCTURAL HEART DEFECT CLOSURE DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2012 63
FIGURE 9 TRANSCATHETER HEART VALVE MARKET SHARE ANALYSIS,
BY KEY PLAYER, 2012 65
FIGURE 10 NUMBER OF PEDIATRIC INTERVENTIONAL CARDIOLOGY PROCEDURES & PREVALENCE OF CHD, BY GEOGRAPHY, 2012–2018 70
FIGURE 11 NORTH AMERICA: NUMBER OF PEDIATRIC INTERVENTIONAL CARDIOLOGY PROCEDURES, 2012–2018 71
FIGURE 12 EUROPE: NUMBER OF PEDIATRIC INTERVENTIONAL CARDIOLOGY PROCEDURES, 2012–2018 72
FIGURE 13 APAC: NUMBER OF PEDIATRIC INTERVENTIONAL CARDIOLOGY PROCEDURES, 2012–2018 73
FIGURE 14 ROW: NUMBER OF PEDIATRIC INTERVENTIONAL CARDIOLOGY PROCEDURES, 2012–2018 75
FIGURE 15 PEDIATRIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY DEVICE TYPE 79
FIGURE 16 OTHER DEVICES 123
FIGURE 17 PEDIATRIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY GEOGRAPHY, 2013 ($MILLION) 132
FIGURE 18 KEY GROWTH STRATEGIES, PEDIATRIC INTERVENTIONAL CARDIOLOGY IMAGING MARKET, 2011–2014 158
FIGURE 19 KEY GROWTH STRATEGIES, PEDIATRIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET, 2011–2014 165

To order this report: Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures – Global Forecasts to 2018
http://www.reportlinker.com/p02063459/Pediatric-Interventional-Cardiology-Market-By-Congenital-Heart-Defect-Closure-Device-[ASD-Ventricular-Septal-Defect-Patent-Ductus-Arteriosus-Left-Atrial-Appendage-Aortic-Valve-Pulmonary-Valve]--Procedures-–-Global-Forecasts-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source

Best of Content We Love 2014 


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.